LRRK2 and Parkinson disease: For instance, only 67.5% of individuals with PD carrying genetic mutations in the leucine-rich repeat kinase 2 (LRRK2) gene were positive for a-syn CSF SAA compared to 93.3% of sporadic PD individuals.